| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11029133 | Oral Oncology | 2018 | 9 Pages |
Abstract
Despite the limitations to comparative effectiveness evaluation in population-based registries, our data suggest that cytotoxic chemotherapy should be used with RT for eligible older HNSCC patients.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Dan P. Zandberg, Kevin Cullen, Soren M. Bentzen, Olga G. Goloubeva,